Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy
about
Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging conceptsCholine metabolism-based molecular diagnosis of cancer: an updateMeta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapyClinical Breast MR Using MRS or DWI: Who Is the Winner?Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatmentA high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T.Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesionsDecrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluationImage guided near-infrared spectroscopy of breast tissue in vivo using boundary element method.Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.Deformable registration for quantifying longitudinal tumor changes during neoadjuvant chemotherapyMagnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerMRI in breast cancer therapy monitoringIn vivo 1H MRS in the assessment of the therapeutic response of breast cancer patientsOptical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review.Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesionsMagnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapyCholine metabolism in malignant transformation.Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI.Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopySerum metabolomics analysis reveals changes in signaling lipids in breast cancer patients.Metabolic tumor imaging using magnetic resonance spectroscopy.Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response AssessmentFunctional imaging: what evidence is there for its utility in clinical trials of targeted therapies?Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancerIn vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literatureEarly prediction of response to neoadjuvant chemotherapy for locally advanced breast cancer using MRIEarly assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI).Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit.MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel (1)H-magnetic resonance spectroscopy and (18)F-fluorodeoxyglucose positron emission tomography.Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy.
P2860
Q26863654-C241F682-E881-4E65-B2F1-EC29C7C595CDQ27024079-CC1FBFCE-1D4E-4571-B0C7-C40C5FB4B596Q27024544-8E394C84-FAF4-4869-8DC2-308BD724F813Q28072837-C8327341-C6AD-4590-BFDB-96A388A92963Q30858109-15E93036-51D7-4C9E-A4AD-7CA72D571FA6Q33517556-9A05429B-FD09-4D7B-9878-AEADCF28E3DFQ33599166-900F5A7C-C21A-4FC7-859D-AADEBB8D77C0Q33746620-F6FD4059-B1FE-4173-BF62-F529A24CCE92Q33783673-36B13BC6-DC5D-42C8-9AC7-4D601716BEABQ33842777-76921242-BD75-48AF-BC81-F056A7A7AD06Q33868006-DCE84EC2-D8D4-427C-ADC4-332165A83097Q33881902-734DDE56-B7D6-4114-86BE-09AA4F992D30Q33938324-07878E86-1E20-4ADA-B250-68873F35B079Q33972737-04A5EC52-AFA0-48F9-9C6D-62DF48925739Q33996547-000F0895-9A33-4135-A97E-602B31E966ADQ34016780-F5B7D8D1-24C2-4EBD-BA57-6A84C4314DC6Q34050338-DE1C3430-C57B-40AC-BDE8-F5879B24875CQ34072785-209ECAB9-1F06-4C01-A581-22C67E12CEF4Q34074868-04722DB3-244C-454E-9C0B-AA5DFB9DFB17Q34415629-5C52C70B-54C2-4721-A740-593A2C3072ABQ35048378-111A3E67-49B4-4288-A4E3-D05BCB8CDDAFQ35075617-B252D320-A054-4EAA-9281-915349FCFA2BQ35112040-1872871D-7CA3-4D1C-9F18-DE903F11BB66Q35148900-0907D1DD-0878-407A-83F2-0D7DA061397EQ35252217-C5BF8E38-673F-4214-A60F-D4A91A0A9749Q35497704-5ED58DBC-CA5A-4E80-A61B-D8274FC33275Q35693105-ADB1ECB5-9879-4F92-A1CB-26FC47C760F8Q35746099-FEA02E6B-97F7-44EB-88FF-640D2F695884Q35784966-4927BA0C-8198-46AF-864C-DB33512F6EB6Q35879814-F0283BE0-92F0-4DD6-9ABF-D24AA117D9E4Q36106087-C6A5BBC0-7538-4148-9A46-D64E19AC86C4Q36245493-95773227-66B8-4A74-8FB7-5223467F1C59Q36797054-9503044D-9E6A-4361-B7AB-B30EB5BFA682Q37254082-93CD86EF-AA89-480C-B8BE-D6006A9ADA89Q37671891-9813F5BD-ED78-4144-91FC-2388472107DCQ37800802-87288449-E5FD-4E93-A8D3-64F2C740A4F7Q37906482-E2B879A5-EF81-4FA6-8D69-60C9E56DF2BCQ38188522-559357DB-7B33-4935-B0EB-9E3054C1DD28Q38422342-94328F3F-7BFD-44B0-AD93-755217FC7169Q38442666-9BAA1C5F-DAED-420D-AAF1-1B3ACD955531
P2860
Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting pathologic response ...... uantitative 1H MR spectroscopy
@en
Predicting pathologic response ...... antitative 1H MR spectroscopy.
@nl
type
label
Predicting pathologic response ...... uantitative 1H MR spectroscopy
@en
Predicting pathologic response ...... antitative 1H MR spectroscopy.
@nl
prefLabel
Predicting pathologic response ...... uantitative 1H MR spectroscopy
@en
Predicting pathologic response ...... antitative 1H MR spectroscopy.
@nl
P2093
P2860
P1433
P1476
Predicting pathologic response ...... uantitative 1H MR spectroscopy
@en
P2093
Hyeon-Man Baek
Jeon-Hor Chen
Min-Ying Su
Orhan Nalcioglu
Rita S Mehta
Shadfar Bahri
P2860
P304
P356
10.1148/RADIOL.2512080553
P407
P577
2009-03-10T00:00:00Z